2 results
Approved WMOCompleted
Part 1: To assess the safety and effectiveness of subcutaneous golimumab 50 mg (SC-GLM50), administered by autoinjection once monthly during 6 months, when combined with different DMARD regimens used in daily rheumatology. Part 2: In subjects who…
Approved WMOCompleted
In this RCT with the duration of 6 months we will examine the longterm (cost) effectiveness of increasing protein intake to 1.2 g/kg body weight/d on physical functioning in community-dwelling older adults with a habitual protein intake < 1.0…